Muscle and Exercise Lecture 2.1 : Gene therapy for DMD: Non - viral strategies Flashcards

1
Q

Name 6 muscle wasting conditions.

A

-Disuse atrophy, when not in use (limb casting/best rest).
-Denervation - spinal cord injury
-Sepsis - systemic infection (in blood)
-Sarcopenia - age related wasting
-Cancer cachexia - cancer related wasting
Muscular dystropy - genetic cause, genetic theraphy most helpful.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the best therapy for a disease with genetic causes?

A

Genetic therapy is best.

Pharmacological treatment prevents secondary consequences only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does genetic therapy do (name 3)?

A

Restores or replaces the defective gene. Can also introduce new gene to help fight diease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is used in cell therapy?

A

Myoblast transfer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is non-viral mediated therapy best for?

A

Altering a gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is viral mediated best for? What is needed to carry it out?

A

Replacing a defective gene. A vector is needed to carry it out.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a common vector?

A

Retrovirus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a gene expression construct? What is it made up of (3)?

A

It is the intervention body.

It needs a promotor, the gene of interest and a stabilising element.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the promotor in a gene expression construct?

A

Promotor is used to induce high levels of expression, or make it cell specific by making it inducible in only certain cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In making a promotor for DMD, it is best to make it specific to which tissue?

A

Muscle tissue (including cardiac).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aside from inducing high expression levels, what else can a promotor do?

A

Allows you to induce manually, such that one can induce when needed and turn off when uneeded.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can the gene of interest in a gene expression construct be easily identified?

A

Adding a tag.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the purpose of a stabilising element in a gene expression construct?

A

Prolongs lifespan of the construct, allowing it to enter the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does cell based therapy differ to genetic therapy?

A

The cell is already modified to express the new gene, is injected into the affected area to replace defective cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In treating DMD, what must the treatment used have to do, and what percentage of muscles must be restored to begin improving function?

A

Must be able to enter both skeletal and cardiac cells, must be specific to them, and must be safe.
Only need 20% restoration to improve quality of life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Whats special about the dystrophin gene? Why is this an issue? How can it be resolved?

A

Its the largest gene in humans. Hard to deliver the entire corrected gene. Can cut out large parts of the gene and still have a functional protein, is truncated.

17
Q

What are the two main non-viral therapy techniques?

A

Unencapsulated plasmid delivery

Dystrophin restoration.

18
Q

What is unencapsulated plasmid delivery, and give a pro/con.

A

Form a plasmid vector with the corrected gene, then inject directly to muscles.
Is safe and simple, but very low efficiency, only 1% of localised cells (injection site, not the whole muscle) epress the gene.

19
Q

How can unencapsulated plasmid delivery be improved (5)?

A

Can combine with other therapies, add a carrier molecule (lipid) and add a DNA stabiliser.
Can use ultrasound to increase permeability.
Also electroporation, but damaging to cells.

20
Q

How can hyaluronidase be used to improve unencapsulated plasmid delivery?

A

It breaks down the extracellular matrix, and improves efficiency when paired with electroporation, not localised to injection site, but the whole muscle.

21
Q

Can unencapsulated plasmid delivery transfer the entire dystrophin gene? Is it permanent?

A

Yes, it can. It is not permanent, is only local to injection site, and repeat injections are needed.

22
Q

Name 2 dystrophin restoration techniques.

A

Stop codon read through

Exon skipping

23
Q

What is stop codon read through? What mutation does it work with?

A

Only works with nonsense mutation, 10-15% of DMD cases.
Is a premature stop codon, truncating the protein.
Stop codon read through uses a drug to allow ribosome to bypass the stop codon and keep reading.

24
Q

What are two drugs in stop codon read through, and what do they interact with? Are they effective?

A

Gentimycin - ribosomal subunit 140s, drops CK levels too, moderately effective.
Ataluren - ribosomal subunit 60s

25
What is exon skipping? What type of mutation does it target? What is a consequence of this?
Targets patients with internal deletions. Restores the mRNA reading frame by skipping an exon downstream of the mutated exon. ie exon 50 deleted, exon 51 skipped. Will have a missing section, but still gives a usable form of dystrophin.
26
What 3 drugs are used in exon skipping? Are they effective?
2MeAON - not very effective Drisapersen - being reviewed PMO - most efficient
27
What is a problem with PMO? What was done to resolve it? What new issue arose?
It didnt affect the heart much. | PPMO was developed, is PMO with a cell permeable peptide added. Is toxicity associated with it however.
28
Which therapies are patient specific?
Stop codon read through | Exon skipping
29
Does exon skipping require repeat injections or is it permanent?
Repeat injections needed.
30
Collectively, what percentage of DMD cases can exon skipping and stop codon read through treat and why?
Only 30% at best due to the nature of their mutation targets.